<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6880</article-id>
      <article-id pub-id-type="doi">10.51847/FGAYclS0YD</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Retrieval-Augmented AI for Interpreting ICH Quality Guidelines and Product Control Strategies</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Petrova</surname>
                <given-names>Elena</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Georgiev</surname>
                <given-names>Ivan</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Stoyanov</surname>
                <given-names>Nikolay</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Kolev</surname>
                <given-names>Petar</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Pharmaceutical AI Systems, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Computational Drug Analytics, Faculty of Engineering, Technical University of Sofia, Sofia, Bulgaria.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>28</day>
        <month>02</month>
        <year>2026</year>
      </pub-date>
      <volume>17</volume>
      <issue>1</issue>
      <fpage>72</fpage>
      <lpage>80</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Pharmaceutical companies face the complex challenge of interpreting and applying ICH quality guidelines while translating general principles into product-specific control strategies, a task made cognitively demanding by variations in modality, dosage form, manufacturing process, and lifecycle stage. Current practices rely heavily on manual document searches, individual expertise, and static templates, which are difficult to scale across diverse product portfolios and evolving regulatory expectations. This article presents a retrieval-augmented AI assistant designed to index ICH quality guidelines, regional regulatory guidance, pharmacopoeial materials, and internal control-strategy documents, enabling natural-language queries about pharmaceutical quality expectations with grounded, citation-backed responses. The system integrates a multi-source ingestion pipeline, a vector database with metadata filtering, a domain-adapted language model, a citation-grounding layer, and a human-review dashboard, emphasizing support for expert interpretation rather than automation of regulatory judgment. By facilitating easier retrieval and comparison of relevant regulatory language, the tool can accelerate the development and review of product-specific control strategies, promote consistency across quality, regulatory affairs, analytical development, and manufacturing teams, and enhance submission readiness while preserving expert oversight, ultimately transforming how pharmaceutical professionals interact with quality guidelines.</p>
      </abstract>
      <kwd-group>
                <kwd>Retrieval-augmented generation</kwd>
                <kwd>ICH quality guidelines</kwd>
                <kwd>Pharmaceutical quality</kwd>
                <kwd>Control strategy</kwd>
                <kwd>Regulatory intelligence</kwd>
                <kwd>GMP</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>